Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum effective concentration of adrenaline for improved surgical field in FESS
ChiCTR2300073776Phase 4Not yet recruiting
- Sponsor
- Tongde Hospital of Zhejiang Province
- Start
- Aug 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of epinephrine in chronic rhinosinusitis (CRS) and nasal polyp, sponsored by Tongde Hospital of Zhejiang Province. Primary endpoints: Surgical field bleeding score and Average blood loss. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
epinephrine
03
Conditions
chronic rhinosinusitis (CRS)nasal polyp
Beyond the preview
Go deeper on ChiCTR2300073776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073776.